Evolving Issues in the Treatment of Depression
JAMA May 24, 2019 Ole Köhler‐forsberg, Cristina Cusin, Andrew A. Nierenberg 18 citations
This Viewpoint discusses recent evidence documenting benefits of nonpharmacological and drug therapies for major depressive disorder including exercise, Mediterranean diet and structured dietary support, ketamine and esketamine, anti-inflammatory drugs, brexanolone, and psilocybin.
DOI: 10.1001/jama.2019.4990 (opens in new tab)
Psilocybin
Ketamine
Major depressive disorder
Depression economics
+6